Anders Bergh

7PUBLICATIONS
31CO-AUTHORS
Molecular targetsInstruments and techniquesTissue engineeringMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 16, 2026
Targeting oncogenic TβRI signaling inhibits androgen-independent prostate cancer growth and metastasis.

|Oct 28, 2025
Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer (HYPO-RT-PC-boost): in silico evaluation with histological reference.

Erik Nilsson, Anneli Nilsson, Joakim Jonsson

|Sep 20, 2024
The TβRI promotes migration and metastasis through thrombospondin 1 and ITGAV in prostate cancer cells.

Yabing Mu, Anders Wallenius, Guangxiang Zang

|May 13, 2023
Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328.

Helena Järemo, Julius Semenas, Sofia Halin Bergström

|Nov 11, 2022
Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy.

Pernilla Wikström, Sofia Halin Bergström, Andreas Josefsson

|Jun 02, 2021
High Monocyte Count and Expression of S100A9 and S100A12 in Peripheral Blood Mononuclear Cells Are Associated with Poor Outcome in Patients with Metastatic Prostate Cancer.

Anna-Maja Åberg, Sofia Halin Bergström, Elin Thysell

Pageof 2

Frequent Collaborators

3 joint publications

Maréne Landström

3 joint publications

Pernilla Wikström

2 joint publications

Jie Song

2 joint publications

Camilla Thellenberg-Karlsson